Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Haematopoietic stem cell transplantation (HSCT) is widely used to treat patients with a range of haematological and non-haematological disorders. Both bone marrow and peripheral blood stem cell collection are associated with morbidity and, very rarely, mortality. We investigated the information that exists to adequately inform donors about the relative merits of each procedure. We carried out a systematic review analysing data from six prospective randomised controlled trials of related donors and discuss here the merits and drawbacks of this approach. Registry data mostly describes patient outcome but stem cell donor registries collect and report information on unrelated donors which could easily be extended to related donors. Further well-designed, randomised studies are required.

Original publication

DOI

10.1111/j.1365-2141.2009.07832.x

Type

Journal article

Journal

Br J Haematol

Publication Date

10/2009

Volume

147

Pages

71 - 76

Keywords

Donor Selection, Evidence-Based Medicine, Health Education, Hematopoietic Stem Cell Transplantation, Humans, Randomized Controlled Trials as Topic, Registries, Tissue Donors, Tissue and Organ Harvesting